Company Filing History:
10 out of 181 
6 out of 97 
5 out of 27 
Years Active: 1981-2017
Title: Sergio Mantegani: Innovator in Pharmaceutical Chemistry
Introduction
Sergio Mantegani, based in Milan, Italy, is a prominent inventor in the field of pharmaceutical chemistry. With an impressive portfolio of 27 patents to his name, Mantegani has significantly contributed to the development of innovative compounds that address serious health challenges.
Latest Patents
Among his latest innovations are the tricyclopyrazole derivatives, which encompass compounds that are either tricyclopyrazole derivatives or pharmaceutically acceptable salts thereof. These patents detail their preparation processes and the pharmaceutical compositions that incorporate these compounds. Notably, they have applications in the treatment of diseases linked to altered protein kinase activity, such as cancer and viral infections, as well as in preventing AIDS development in HIV-infected individuals. Additionally, these compounds are relevant for addressing cell proliferative disorders, autoimmune, and neurodegenerative disorders. The patents also disclose processes under Solid Phase Synthesis conditions for preparing these compounds and the creation of chemical libraries comprising a variety of them.
Career Highlights
Sergio Mantegani has worked with notable companies, including Farmitalia Carlo Erba S.p.A. and Pharmacia & Upjohn S.p.A., where he has played an instrumental role in research and development. His contributions have facilitated advancements in drug development and therapeutic strategies.
Collaborations
Throughout his career, Mantegani has collaborated with other esteemed professionals, including Aldemio Temperilli and Gabriella Traquandi. These partnerships have likely enriched his research and expanded the impact of his innovations in the pharmaceutical industry.
Conclusion
Sergio Mantegani stands as a notable figure in the realm of pharmaceutical innovations. His extensive array of patents reflects a deep commitment to improving healthcare outcomes through scientific advancements. With continued contributions, Mantegani is poised to influence the industry further, developing compounds that address critical health issues.